Gene Therapy for Fanconi Anemia
Condition(s):Fanconi AnemiaLast Updated:July 11, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Fanconi AnemiaLast Updated:July 11, 2023Active, not recruiting
Condition(s):B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Mixed Phenotype Acute Leukemia; Recurrent B Acute Lymphoblastic Leukemia; Recurrent Mixed Phenotype Acute LeukemiaLast Updated:December 20, 2023Recruiting
Condition(s):B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeLast Updated:October 10, 2023Recruiting
Condition(s):Double-Expressor Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 RearrangementsLast Updated:June 7, 2023Recruiting
Condition(s):Diffuse Large B-Cell Lymphoma; High Grade B-Cell LymphomaLast Updated:February 8, 2024Not yet recruiting
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:January 5, 2024Recruiting
Condition(s):Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell LymphomaLast Updated:December 7, 2023Recruiting
Condition(s):Castration-Sensitive Prostate Carcinoma; Metastatic Prostate Adenocarcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8Last Updated:January 3, 2024Recruiting
Condition(s):Aggressive Non-Hodgkin Lymphoma; B-Cell Non-Hodgkin Lymphoma; CD20 Positive; Diffuse Large B-Cell Lymphoma Unclassifiable; Intravascular Large B-Cell Lymphoma; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaLast Updated:August 15, 2022Suspended
Condition(s):Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin LymphomaLast Updated:October 30, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.